{"chebi_id":"68579","chebi_name":"rivaroxaban","chebi_synonyms":["5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide","BAY59-7939","BAY 59-7939","Xarelto"],"diffprof_id_observed":["MTBLS5828_0002_00000001"],"diffprof_id_var_observed":[],"inchikey":"KGFYHTZWPPHNLQ-AWEZNQCLSA-N","inn_name":"rivaroxaban","iupac_name":"5-chloro-<em>N</em>-({(5<i>S</i>)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide","num_study_observed":1,"reactome_ids":["R-HSA-109582","R-HSA-140875","R-HSA-140877"],"reactome_names":["Hemostasis","Common Pathway of Fibrin Clot Formation","Formation of Fibrin Clot (Clotting Cascade)"],"study_id_observed":["MTBLS5828"],"study_id_var_observed":[],"synonym_name":"BAY59-7939"}
